Aviva Systems Biology

Offering antibodies to more than 7000 different targets, many that are implicated in transcription, epigenetics and cell signalling, Aviva Systems Biology leverages a high throughput antibody production process to release over 200 new antibody products every month. These complement a portfolio that already covers most members of key protein families - including transcription factors, transcription regulators, RNA binding proteins, ion channels and cell membrane proteins – underscoring Aviva’s reputation as a leader of novel proteomic discoveries.